Menu

Infographic: Selective Autophagy

Xenophagy targets bacterial pathogens for destruction, while mitophagy aids red blood cell maturation.

Feb 28, 2018
Vikramjit Lahiri and Daniel J. Klionsky

In contrast to nonselective autophagy, which digests various cellular cargos randomly, selective versions of this process can target specific molecules, organelles, or even whole organisms for degradation. For example, during the maturation of oxygen-transporting red blood cells called erythrocytes, a selective form of autophagy known as mitophagy eliminates most mitochondria from precursor cells called reticulocytes. Another type of selective autophagy, called xenophagy, involves the targeted digestion of bacterial pathogens. 

© N.R.FULLER, SAYO-ART LLC

© N.R.FULLER, SAYO-ART LLC

Read the full story.

Correction (March 2): The author listed on the original online version of this article was incorrect. The byline is now fixed. The Scientist regrets the error.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!